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Eukaryotic systemsOver the last years protein engineering using non-standard amino acids has gained increasing atten-
tion. As a result, improved methods are now available, enabling the efﬁcient and directed cotrans-
lational incorporation of various non-standard amino acids to equip proteins with desired
characteristics. In this context, the utilization of cell-free protein synthesis is particularly useful
due to the direct accessibility of the translational machinery and synthesized proteins without
having to maintain a vital cellular host. We review prominent methods for the incorporation of
non-standard amino acids into proteins using cell-free protein synthesis. Furthermore, a list of
non-standard amino acids that have been successfully incorporated into proteins in cell-free
systems together with selected applications is provided.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Nature has evolved a set of 20 primary building blocks – the
proteinogenic or standard amino acids (sAAs) – serving as sub-
strates in ribosome-mediated protein synthesis in almost all living
organisms. Exceptionally, this natural repertoire is expanded by
selenocysteine [1] and pyrrolysine [2,3] that are translationally
incorporated only in certain species. Based on their biochemical
and biophysical characteristics this ﬁnite number of amino acids
limits the ability to directly study proteins but thereby deﬁnes
the possible chemical space of protein chemistry [4]. Chemical
synthesis bears the potential to generate a vast variety of
non-standard amino acids (nsAAs) with a tremendous amount of
possible characteristics exceeding the natural repertoire of primary
protein building blocks [5,6]. With the objective of supporting
biological investigations as well as creating proteins with novel
characteristics scientists have developed methods in order to
cotranslationally incorporate a variety of different nsAAs intoproteins. In the following we review some of the most prominent
approaches with special emphasis on their use in the context of
cell-free protein synthesis (CFPS). Although the methods presented
here have mainly been applied in Escherichia coli based cell-free
systems (for a more concise presentation please refer to [7] and
[8]) this article aims at pointing out key features that support their
transfer to eukaryotic CFPS. Finally we provide an overview on
diverse nsAAs that have been successfully employed in different
CFPS systems (Fig. 1 and Table 1) together with a presentation of
selected applications.
2. Cell-free protein synthesis
CFPS also termed in vitro protein translation has emerged as a
versatile technology to complement cell-based protein expression
[9–12]. CFPS utilizes the translational machinery of cells obtained
either by preparation of crude cell extracts or the reconstitution
of puriﬁed components. By addition of an appropriate template
that can be either DNA or mRNA protein synthesis is directed
towards the predominant production of a desired protein. Until
today CFPS based on a variety of different sources including
E. coli [13–16], Leishmania [17], Thermus [18], wheat germ
[19,20], tobacco [21], insect [22–24], yeast [25], rabbit reticulo-
cytes [26], CHO [27], mouse [28] and human cells [29,30] has been
demonstrated. Different reaction modes are available that enable
transcription and translation to be performed separately (linked
Table 1
List of nsAAs that have been incorporated using cell-free protein synthesis. The entry numbers correspond to numbers given in Fig. 1. It
should be noted that this list is not intended to be exhaustive. Abbreviations used: rs = residue-speciﬁc; pc = precharged tRNA;
op = orthogonal tRNA/synthetase pair; fs-tRNA = frame-shift-tRNA; s-tRNA = stop-codon-suppressor-tRNA; RR = rabbit reticulocyte;
WG = wheat germ.
Entry Non-standard amino acid Methodology
1 4-Fluorotryptophan rs (E. coli [80])
2 4-Methyltryptophan rs (E. coli [80])
3 5-Fluorotryptophan rs (E. coli [80])
4 5-Hydroxytryptophan pc s-tRNA (E. coli [181])
5 5-Methyltryptophan rs (E. coli [80])
6 6-Fluorotryptophan rs (E. coli [80])
7 6-Methyltryptophan rs (E. coli [80])
8 7-Azatryptophan rs (E. coli [80]); pc fs-tRNA (E. coli [162]); pc s-tRNA
(E. coli [126,181])
9 Azidohomoalanine rs (E. coli [130,178])
10 2-Naphthylalanine pc fs-tRNA (E. coli [111]; Sf21 [115])
11 2-Anthrylalanine pc fs-tRNA (E. coli [132])
12 Acetyl-lysine op s-tRNA (E. coli [182])
13 Dansyl-lysine pc s-tRNA (E. coli [126,181])
14 Homophenylalanine pc s-tRNA (E. coli[125])
15 para-Nitrophenylalanine pc s-tRNA (E. coli [125]); pc fs-tRNA (E. coli
[111,113,164]; RR [113]; Sf21 [115])
16 para-Fluorophenylalanine pc s-tRNA (E. coli [125])
17 para-Triﬂuoromethylphenylalanine op s-tRNA (E. coli [127])
18 para-Iodophenylalanine pc s-tRNA (E. coli [183])
19 para-Azidophenylalanine op s-tRNA (E. coli [63,108,128,169,171,172,178,179];
Sf21 [107])
20 para-Azidomethyl-phenylalanine op s-tRNA (E. coli [177])
21 para-Acetylphenylalanine op s-tRNA (E. coli [95,128,171])
22 para-Benzoylphenylalanine pc s-tRNA (E. coli [126,128]; RR [175]); pc fs-tRNA
(E. coli/RR [113])
23 para-Bipyridylphenylalanine op s-tRNA (E. coli [128,145])
24 2-Methyltyrosine op s-tRNA (E. coli [171])
25 3-Iodotyrosine op s-tRNA (WG [154])
26 3-Chlorotyrosine pc s-tRNA (WG [124])
27 3-Azidotyrosine pc s-tRNA (WG [170]); op s-tRNA (E. coli [173])
28 Propargyloxyphenylalanine op s-tRNA (E. coli [63,95,108,174,176,178])
29 Allylglycine pc s-tRNA (E. coli [184])
30 Homopropargylglycine rs (E. coli [130,178,179])
31 Selenomethionine rs (E. coli [155])
32 Biocytin and derivatives pc s-tRNA (RR [185]); pc fs-tRNA (E. coli [186]
33 L-3,4-Dihydroxyphenylalanine rs (E. coli [187])
34–39 Glycosylated serine derivatives pc s-tRNA (E. coli/RR [167])
40–45 Glycosylated tyrosine derivatives pc s-tRNA (E. coli/RR [167])
46 Dabcyl-diaminopropionic acid pc s-tRNA (E. coli [162])
47 b-Anthraniloyl-L-a,b-diaminopropionic acid pc fs-tRNA (E. coli [133,164])
48 (7-Hydroxy-coumarin-4-yl)ethylglycine op s-tRNA (E. coli [127,128,158])
49 Bodipy-FL-aminophenylalanine and derivatives pc fs-tRNA (E. coli [156,159,188]); s-tRNA (E. coli [188])
50 Bodipy558-aminophenylalanine pc fs-tRNA (E. coli [188])
51 4-[(6-[Tetramethylrhodamine-5-(and-6)-
carboxamido]hexanoyl)amino]phenylalanine
pc fs-tRNA (E. coli [156,163])
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[8]. Even linear PCR products can be used as gene templates
signiﬁcantly reducing time expenses by circumventing laborious
cloning steps [31–33]. Lacking the cellular plasma membrane the
open environment of CFPS enables the direct manipulation of
the protein translation process to achieve a tailored protein
production. Therefore, CFPS is a promising tool for the
synthesis of difﬁcult-to-express proteins [8,34]. For example, the
over-expression of toxic and membrane proteins is strongly facili-
tated due to the fact that CFPS lacks constrains accompanied by cell
vitality. In general, the choice of appropriate synthesis conditions
has to be determined in accordance with the individual protein
to be expressed in order to obtain maximum yields of properly
folded and functional products. In this context, prokaryotic sys-
tems are characterized by comparatively high protein yields but
due to the limited capability to perform sophisticated
post-translational modiﬁcations e.g. phosphorylation, glycosyla-
tion and signal peptide cleavage, the synthesis of functional
eukaryotic proteins can be improved using cell-free systems based
on extracts derived from cultured eukaryotic cells.2.1. Unique features of eukaryotic cell-free systems
Over the last years, systems derived from wheat germ embryos
have become the most recognized eukaryotic CFPS systems (for a
detailed overview please refer to [35]). A multitude of different
proteins have been successfully synthesized using wheat germ
extracts, illustrating its versatility and in particular the conve-
nience of a eukaryotic translation and folding machinery.
Nevertheless, cell-free wheat germ systems lack the capability to
perform post-translational modiﬁcations, which can clearly have
a signiﬁcant impact on protein folding and corresponding function-
ality. Interesting developments in the extract preparation proce-
dure have enabled the production of eukaryotic cell-free systems
based on crude extracts from cultured tobacco BY-2 [21], Sf21
[36,37], CHO and human K562 [38] cells that contain endogenous
microsomal structures. These lipid bilayers have been found to
carry out some of the functions of the endoplasmic reticulum
thereby providing PTMs such as protein N-glycosylation [37,39],
lipid modiﬁcations [40] and signal peptide cleavage [41]. They fur-
ther support active cotranslational translocation of proteins
Fig. 1. Non-standard amino acids that have been incorporated in cell-free protein synthesis systems. 1–8 Tryptophan-analogs: (1) 4-ﬂuorotryptophane (4FW); (2) 4-
methyltryptophane (4MW); (3) 5-ﬂuorotryptophane (5FW); (4) 5-hydroxytryptophane (5OHW); (5) 5-methyltryptophane (5MW); (6) 6-ﬂuorotryptophane (6FW), (7) 6-
methyltryptophane (6MW); (8) 7-azatryptophane (7azaW). 9–11 Alanine-analogs: (9) azidohomoalanine (Aha); (10) 2-naphthylalanine (2NpA); (11) 2-anthrylalanine
(AntA). 12–13 Lysine-analogs: (12), acetyl-lysine (AcK); (13) Dansyl-lysine (DaK). 14–23 Phenylalanine-analogs: (14) homophenylalanine (hF); (15) para-nitrophenylalanine
(pNF); (16) para-ﬂuorophenylalanine (pFF); (17) para-triﬂuoromethylphenylalanine (tFmF); (18) para-iodophenylalanine (IoF); (19) para-azidophenylalanine (AzF); (20)
para-azidomethylphenylalanine (AzMeF); (21) para-acetylphenylalanine (AcF); (22) para-benzoylphenylalanine (Bpa); (23) para-bipyridylphenylalanine (Bpy). 24–28
Tyrosine-analogs: (24) 2-methyltyrosine (2MeY); (25) 3-iodotyrosine (3IY); (26) 3-chlorotyrosine (3ClY); (27) 3-azidotyrosine (3AzY); (28) propargyloxyphenylalanine (Ppa).
29–30 Glycine-analogs: (29) allylglycine (AlG); (30) homopropargylglycine (HpG). 31–33 Other non-standard amino acids: (31) selenomethionine (SeM); (32) biocytin (Bct);
(33) L-3,4-dihydroxyphenylalanine (L-DOPA). 34–39 Glycosylated serine-analogs; 40–45 glycosylated tyrosine-analogs (see reference for structural details). 46–47 Quencher-
amino acids: (46) dabcyl-diaminopropionic (Dbc); (47) b-anthraniloyl-L-a,b-diaminopropionic acid (Adp). 48–51 Fluorescent amino acids: (48) (7-hydroxy-coumarin-4-
yl)ethylglycine (Hco); (49) bodipy-FL-aminophenylalanine (BODIPY-FL-Phe); (50) Bodipy558-aminophenylalanine (BODIPY558-Phe); (51) 4-[(6-[tetramethylrhodamine-5-
(and-6)-carboxamido]hexanoyl)amino]phenylalanine (TAMRA-X-Phe).
R.B. Quast et al. / FEBS Letters 589 (2015) 1703–1712 1705containing an appropriate signal peptide into the lumen of these
microsomes [42]. This nature like compartmentalization was found
to facilitate the correct formation of disulﬁde bonds yielding a set
of different functional single chain antibody fragments [43].
Moreover, embedment of integral membrane proteins into these
natural membranes provides a platform for the direct functional
characterization in a nature-like environment [37,44].
2.2. Improving yields and scaling eukaryotic CFPS
Unfortunately, the majority of eukaryotic cell-free systems
available suffer from comparatively low total protein yields.
Exceptions are CFPS systems based on extracts from wheat germembryos. These systems provide the production of milligram
amounts of target proteins within a few days [35]. Different
approaches that have facilitated the development of high-yielding
systems fromwheat germ embryos have been found to be transfer-
able to other eukaryotic systems. For instance, the utilization of
viral internal ribosome entry sites (IRES) has just recently been
demonstrated to increase translation rates in cell-free yeast [45],
insect, CHO and human systems [46]. In particular, IRES sequences
that provide a translation initiation independent of the 50-cap struc-
ture such as the cricket paralysis virus intergenic region IRES
thereby circumvent the major bottleneck of eukaryotic translation
initiation in CFPS [47]. Moreover, different reaction formats such
as continuous exchange (CECF) and continuous ﬂow (CFCF) have
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increased protein yields [48]. In particular, the CECF approach bears
the potential to be widely employed due to an easy-to-handle
methodology that is based on a simple dialysis chamber composed
of a reaction and a feeding compartment separated by a
semi-permeable membrane. In a recent study, its compatibility
with the before-mentioned microsome-containing Sf21 system
was demonstrated [24]. Additionally, the CECF approach has been
shown to be scalable up to several milliliters of reaction volume
using a cell-free system derived from HeLa cells [49].
3. Methods for cell-free nsAA incorporation
3.1. The genetic code and its expansion
In the cellular context, proteins are synthesized based on the
information deﬁned in the genetic code. This information arises
from the sequential alteration of triplet codons composed of the
four bases A, G, C and T [50]. With 61 sense codons coding for
the 20 sAAs and 3 non-sense codons providing a signal to termi-
nate protein translation the code is degenerated [51]. The genetic
information is delivered to the cell’s integral protein synthesis
machinery – the ribosome – in the form of the mRNA transcript.
Inside the ribosome, the actual decoding is mediated by tRNAs that
serve as adapter molecules through base-pairing of their anticodon
with complementary triplet codons in the mRNA [52]. Being
charged with their cognate amino acids, tRNAs provide the ribo-
some with the protein building blocks and decisively determine
the incorporation of a particular amino acid in response to deﬁned
codons [53,54]. In the early 1960s Chapeville and colleagues were
able to prove Cricks adapter hypothesis by incorporating Ala using
an Ala-tRNACys that was obtained by reducing Cys-tRNACys [55].
Using E. coli cell-free translation, this demonstrated the possibility
to incorporate amino acids in response to a desired codon by
employment of selected tRNA species charged with non-cognate
substrates.
3.2. Misacylation of tRNAs
The term ‘‘misacylation’’ refers to the aminoacylation of a tRNA
with a non-cognate amino acid [6,56]. In their natural context,
tRNAs are enzymatically aminoacylated with their cognate amino
acids by highly speciﬁc aminoacyl-tRNA synthetases (aaRS) [57].
Their amino acid speciﬁcity is determined by the amino acid bind-
ing pocket and for some aaRSs, an editing domain providing
hydrolysis of misacylated tRNAs [58]. Since evolution of the
aaRS’s speciﬁcity was mainly driven by the correct selection
between amino acids present in a given system, it is not surprising
that a number of nsAAs has been found to bypass this quality con-
trol thereby being selected for protein synthesis [4,59].
Nevertheless, many nsAAs bearing desirable characteristics are
not readily accepted at the level of the aaRS, as these enzymes
ensure the formation of correctly aminoacylated tRNAs with an
accuracy of at least 10000:1 [60]. However, engineering of selected
aaRSs made it possible to alter their amino acid substrate speci-
ﬁcity [61]. Unfortunately, it has been shown in vitro, that extensive
mutagenesis, even though providing the desired alteration of sub-
strate speciﬁcity, often impairs the catalytic activity of aaRSs mak-
ing them rather inefﬁcient compared to their natural ancestors
[62–64]. Besides the enzymatic misacylation of tRNAs different
groups have contributed to the establishment of an alternative
technology leading to aminoacyl-tRNAs (aatRNA) via a synthetic
route [65–70]. This straightforward approach offers implementa-
tion of a broader range of nsAAs such as larger organic ﬂuorescent
dyes as no aaRSs are involved [27,37,39]. Nevertheless, this proce-
dure remains limited by the elongation factor recognition ofaatRNAs [71,72] and also steric hindrance by adjacent amino acid
side chains seems to play an important role [37]. Alternatively,
Suga and coworkers have evolved ribozymes catalyzing the
aminoacylation of tRNAs in a versatile, rather than a speciﬁc man-
ner [73]. Further improvements of their technology have yielded
catalytic RNAs denoted as Flexizymes, offering a broad tRNA and
amino acid substrate speciﬁcity [74]. Immobilized on a resin, they
enable an easy-to-handle methodology to obtain aatRNAs that can
subsequently be used for the incorporation of nsAAs into peptides
and proteins in cell-free synthesis [75–77].
3.3. Sense codon reassignment
In principle, any of the 61 sense codons can be reassigned to
incorporate nsAAs resulting in a residue-speciﬁc replacement of a
sAA. The relative amount of residue-speciﬁc nsAA incorporation
into protein can be partial to quantitative. Depending on the fre-
quency of the codons employed, this methodology either leads to
a single nsAA or multiple nsAAs in the translated protein [78]. In
the 1950s, Cohen and coworkers demonstrated the tolerance of
the translational machinery towards analogues of the sAAs by
globally replacing Met by SeMet in E. coli [79]. In the context of
cell-free protein synthesis, this requires extract preparation from
auxotrophic strains [80] or depletion of the entire sAA pool by
size-exclusion chromatography during extract preparation [27].
Subsequently, the reaction is supplemented with the desired
repertoire of amino acids including the nsAAs but missing the
sAA to be replaced. In contrast, the addition of a nsAA to the pool
of all canonical amino acids induces a competition between one
of the sAAs and its non-standard analogues resulting in a statistical
incorporation of the nsAA depending on the relative ratio of the
two types amino acid species. In the same manner pre-charged
tRNAs can be used to introduce nsAAs, which is particularly useful
if no aaRS accepting the desired nsAA is available. Accordingly, in
the presence of the complete endogenous pool of tRNAs the nsAA
is incorporated statistically as long as it is compatible with the
translation machinery. This is due to a competition of aatRNAs
decoding the same codons [39,44,81]. If an efﬁcient and
site-directed incorporation is desired, the use of exogenous
tRNAs acting orthogonal to the host system is required. Thus, the
tRNA may not be aminoacylated or deacylated by endogenous
aaRSs. In the ﬁrst instance, tRNA orthogonality arises from signiﬁ-
cant structural differences between the three domains of life
[82,83]. Nevertheless, further efforts have been made to enhance
orthogonality by tRNA evolution [84]. To achieve a global reassign-
ment of a selected codon cell-free extracts can also be depleted of
endogenous tRNAs, followed by a subsequent supplementation
with only the desired tRNA species [85,86]. In theory, this would
enable the use of multiple codons for the parallel incorporation
of different nsAAs. Since cell-free protein synthesis is programmed
by the addition of an appropriate gene template (either DNA or
mRNA depending on the reaction mode), site-directed mutagenesis
can be integrated during template generation to control the fre-
quency and location of codons used for nsAA incorporation.
Appropriate templates can be obtained either by gene synthesis
or simply by PCR using mismatch primer pairs as the linear DNA
products can directly be employed in CFPS. In particular, rare
codons are considered to be promising targets for reassignment
in order to expand the natural repertoire of sAAs [87]. Among
the cell-free synthesis systems currently available, the PURE
system represents the only system, which is completely
reconstituted from recombinantly tagged protein factors puriﬁed
to homogeneity. This E. coli-based system is an ideal candidate
for the substitution of amino acids, tRNAs, aaRSs and other
translational components that support nsAA incorporation [88].
In contrast, the complete reconstitution of a cell-free systems from
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larger amount of proteins being involved in eukaryotic protein
translation, in particular the initiation phase. Therefore, the
utilization of elements that provide translation initiation indepen-
dent of eukaryotic initiation factors such as viral IRES sequences
can be a considered a ﬁrst step towards the development of such
systems.
3.4. Stop codon suppression
Of the 64 codons arising from the combination of the four
nucleobases in triplets, 3 codons are used to terminate the transla-
tion of mRNA into protein. This is achieved by interaction with the
release or termination factors (RFs). However, certain organisms
exhibit an expanded genetic code to incorporate selected amino
acids in response to a stop codon [89]. This principle is referred
to as stop codon suppression and is mediated by suppressor
tRNAs that contain an anticodon complementary to the respective
stop codon. Examples comprise selenocysteine being encoded by
the opal codon [1] and pyrrolysine by the amber codon [2,3].
Stop codon suppression, in particular amber codon suppression,
has emerged to be the most widely used method to incorporate
nsAAs in a site-directed manner. Thereby, the desired position
can be easily determined by site-directed mutagenesis. Due to a
competition of the RFs and the suppressor tRNA for interaction
with the stop codon, usually two types of translation products
are obtained: the truncated termination product and the
full-length suppression product containing the desired nsAA [81].
Several attempts have been made to improve the suppression efﬁ-
ciency, thereby increasing the amount of full-length suppression
product. In this context, it is beneﬁcial to incorporate nsAAs in
open CFPS as these systems lack the cellular plasma membrane
and therefore the translation reaction can be directly inﬂuenced
by the addition or removal of components. In prokaryotes RF1
speciﬁcally recognizes the amber codon (UAG) whereas RF2 recog-
nizes the opal codon (UGA). Termination in response to the ochre
codon (UAA) is mediated by overlapping speciﬁcity of both RFs
[90]. Based on this knowledge, a cell-free RF1-depleted E. coli sys-
tem has been generated that exhibits signiﬁcantly increased sup-
pression efﬁciency with C-terminal termination being mediated
by RF2 recognizing the ochre codon [91]. Moreover, heat inactiva-
tion of thermo-sensitive RF1 variants [92] as well as RF1 inhibition
by aptamers [93] and antibodies [94] have been successfully
implemented in CFPS systems. Hong and colleagues just recently
demonstrated the incorporation of multiple nsAAs in response to
stop codon suppression using extracts from a genetically recoded
E. coli strain lacking RF1 [95]. Unfortunately, the approaches men-
tioned above cannot directly be transferred to eukaryotes, since the
eukaryotic release factor 1 (eRF1) is responsible for translation ter-
mination in response to all stop codons [96]. In particular, the posi-
tion of the stop codon to be suppressed plays an important role as
it has been found that suppression efﬁciency is higher the more
N-terminal the codon is positioned [37]. Nevertheless, the use of
an aptamer in Xenopus oocytes has been shown to slightly increase
amber suppression by 3-fold [97]. Additionally, a recent study
reported the use of a HEK 293T strain with an engineered eRF1 that
increased amber suppression at a single site 17- to 20-fold making
this strain a valuable source for future extract preparation [98].
3.5. Orthogonal tRNA/synthetase pairs
The site-directed incorporation of nsAA into proteins based on
the utilization of synthetically charged suppressor tRNAs suffers
from exhaustion of the aatRNA pool over time. In contrast, the
expansion of a given system by an orthogonal aaRS (oRS) that
speciﬁcally aminoacylates orthogonal suppressor tRNAs (otRNA)with nsAAs, provides a continuous replenishment of charged sup-
pressor tRNAs. Orthogonality refers to a lack of cross-reactivity in a
given system. In the ideal case, an efﬁcient and site-directed incor-
poration of nsAAs is achieved when (i) the otRNA is not a substrate
for any of the endogenous synthetases and thus is not charged with
a sAA, (ii) the oRS does not aminoacylate any endogenous tRNAs
with the nsAA and (iii) the oRS exhibits a high speciﬁcity for the
nsAA and does not accept sAAs as substrates. To meet these
requirements, otRNA/oRS pairs are usually imported from phyloge-
netically distant organisms [99]. For example, archeal wild type
PylRS together with its cognate amber suppressor tRNAPyl has
been directly employed to incorporate a set of different Pyl ana-
louges in E. coli [100,101] as well as in mammalian cells [102].
Nevertheless, engineering of aaRSs is often required to further
enhance orthogonality and efﬁcient aminoacylation of suppressor
tRNAs, but also to alter the oRS’s amino acid speciﬁcity
[61,103,104]. For this purpose, screening methods for the evolution
of pairs orthogonal in bacteria and eukaryotes have been estab-
lished that are based on E. coli [105] and Saccharomyces cerevisiae
[106] cells, respectively. Up to now, approximately 100 of such
orthogonal translation systems (OTS) have been established [64].
Although, strongly facilitating nsAA incorporation in living cells,
their employment in the context of CFPS offers a range of different
advantages. As mentioned above engineered oRS often exhibit low
activities compared to their natural ancestors especially towards
non-cognate suppressor tRNAs [62–64]. To account for this, the
open environment of CFPS allows for the addition of deﬁned
amounts of puriﬁed oRS, otRNA and nsAA to support maintenance
of a competitive pool of aatRNAs [107]. Using eukaryotic CFPS in
combination with an E. coli derived OTS comprising an amber
suppressor tRNA that lacks modiﬁed nucleotides, increased Mg2+
concentration have further been found to be beneﬁcial [107].
Furthermore, cytotoxic effects during cell growth, which are often
associated with the overexpression of oRSs, otRNAs and the
supplemented nsAA itself are circumvented and the preliminary
synthesis of the target protein is supported [7]. In this way, even
high incorporation efﬁciencies of poorly soluble nsAAs can be
achieved [108].
3.6. Frame-shift codons
The use of frame-shift codons is based on tRNAs with an
extended anticodon loop which results in decoding of codons
exceeding three nucleobases [109]. In this manner, four-base and
even ﬁve-base codons have been successfully employed for the
incorporation of nsAAs in cell-free protein synthesis [110,111]. In
particular, the use of quadruplets derived from rarely employed
codons provides an efﬁcient competition with endogenous tRNAs
decoding the respective triplet codon [112]. In order to easily dis-
criminate between the frame-shift product and the in-frame trans-
lated protein, the codon context is designed in a way that
translation is terminated upon triplet decoding [113]. Using
synthetically acylated aatRNAs decoding four-base codons Sisido
and coworkers achieved a higher incorporation efﬁciency of
nsAAs compared to amber suppression and demonstrated the
incorporation of multiple nsAAs in a cell-free E. coli system [111].
Moreover, frame-shift decoding has been transferred to eukaryotic
cell-free systems including rabbit reticulocytes and Sf21 extracts
[114,115]. Besides the synthetic acylation, it has been shown that
four-base decoding tRNAs can also be charged enzymatically
[116,117].
3.7. Orthogonal ribosomes
In order to further improve incorporation yields in response to
amber suppression, the Chin lab developed orthogonal ribosomes
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Shine-Delgarno sequence in E. coli [118]. Based on the coexistence
of wild-type and orthogonal ribosomes an elegant selection
method enabled evolution of an orthogonal ribosome referred to
as Ribo-X [119]. Employment of Ribo-X enabled a signiﬁcantly
increased amber suppression rate of orthogonal mRNA resulting
from a decreased RF1 termination efﬁciency [120]. Furthermore,
another ribosome mutant, ribosome Q, was found to effectively
decode four-base codons. By employment of the two different
mutants incorporation of two nsAAs in response to amber suppres-
sion and quadruplet decoding was demonstrated in vitro [121].
3.8. Unnatural base-pairs
The use of unnatural base pairs for the generation of unique
codons to be employed for the site-directed incorporation on
nsAAs represents a promising alternative to the methods described
above. Unfortunately, their utilization is impaired by a variety of
different problems. Ideally, they must serve as substrates for RNA
and DNA polymerases, elongation factors and ribosomes [4].
Moreover, a sufﬁcient orthogonality towards the natural nucle-
obases is required. The development of unnatural base-pairs
including advantages and limitations was recently reviewed by
Hirao and Kimoto [122]. Although, it has been demonstrated that
unnatural base-pairs can be efﬁciently suppressed and provide
incorporation of nsAAs into proteins in cell-free synthesis, their
application still requires further improvements [123,124].
4. Cell-free applications
As explained above, the cell-free approach to incorporate nsAAs
beneﬁts from a comparatively high economical efﬁciency. In par-
ticular, this is desired when expensive substrates are used that
contain for example stable isotopes or ﬂuorescent dyes. Early on,
CFPS was employed in order to investigate the translational ﬂexi-
bility of the protein synthesis apparatus [113,115,125,126].
Moreover, it enables the study of parameters and kinetics inﬂuenc-
ing tRNA misacylation and amber suppression [63,108,127,128].
Novel orthogonal systems can be characterized in vitro in terms
of substrate speciﬁcity and efﬁciency [101]. The ﬁnal goal of
nsAA incorporation is to increase the chemical diversity of proteins
(Fig. 1). This may serve to alter protein function [129,130], to intro-
duce new functions [131] or to incorporate biophysical probes or
reactive handles for protein conjugation.
4.1. Biophysical probes
The signiﬁcance of a directed incorporation of biophysical
probes into proteins is striking, as they allow for highly sensitive
detection methods that can be used for quantiﬁcation purposes
as well as structural investigations and many of them do not
impede protein function [80,132,133]. CFPS with stable isotope
labeled amino acids represents an advantageous method especially
in the ﬁelds of FT-IR, NMR characterization and MS quantiﬁcation
[134–138]. Cell-free production of stable isotope labeled proteins
occurs under optimized conditions with minimized amounts of
costly amino acids [139–151]. This is due to the fact that amino
acid metabolic pathways are impaired during cell extract prepara-
tion and speciﬁc inhibitors can be employed which minimizes
scrambling [152]. Extracts can also be dialyzed to remove endoge-
nous amino acids in order to decrease dilution. In addition to
13C/15N-labeled amino acids, 19F-substituted nsAAs can be
employed for background-free NMR studies [80,127]. 19F is also a
valuable biophysical probe because of its chemical shift sensitivity
towards the local environment [153]. Furthermore, the use ofheavy atom-substituted amino acids strongly facilitates X-ray crys-
tallographic structure determinations [154,155].
Another important class of biophysical probes comprises ﬂuo-
rescent nsAAs. Fluorescent labeling strategies represent a popular
method of investigation due to the high sensitivity of ﬂuorescent
probes. Fluorescent nsAAs may also serve as a quick method for
the determination of protein yields, eliminating the need for radi-
olabeling, liquid scintillation counting and exposition on phospho-
storage screens [127,128]. The ﬂuorescent probes can be
incorporated site-speciﬁcally to give information about protein
localization, conformation and interactions [156–158].
Incorporation of multiple ﬂuorescent nsAAs enables intramolecu-
lar investigations of protein conformation and integrity. Using pre-
charged frameshift-tRNAs, the group of Sisido incorporated two
different BODIPY derivatives into calmodulin and was able to
observe changes in the FRET signal upon ligand-binding [159].
This report demonstrates the usefulness of small molecular dyes
for FRET-studies. In the past, genetic fusions of green ﬂuorescent
protein derivatives were applied to monitor conformational
changes and protein interactions [160]. The presence of these
high-molecular weight (>25kDa) fusion proteins reportedly posed
restrictions on protein folding and interactions [161], which can
be circumvented with ﬂuorescent nsAAs. Using a mixed approach
with amber suppression and four-base decoding, Anderson et al.
demonstrated the ability to monitor protein integrity by FRET
[162]. In another example, a ﬂuorescent nsAA was used to screen
for MMP-9 inhibitors by ﬂuorescence correlation spectroscopy
[163]. Moreover, by incorporating a pair of donor/quencher
nsAAs into streptavidin, the group of Sisido also demonstrated that
this approach yields information about the local protein structure
[164]. The binding event of biotin at streptavidin was monitored
by incorporated nsAA as well [132,133].
4.2. Protein conjugation
One of the most anticipated ﬁelds of applying nsAAs deals with
the equipment of proteins with natural and synthetic
post-translational modiﬁcations (PTMs). Naturally occurring
PTMs inﬂuence stability, functionality but also localization and
interactions of the corresponding modiﬁed proteins [165].
However, strong evidence supports a complex crosstalk of different
PTM signals but the large diversity makes it difﬁcult to speciﬁcally
assign certain functions to individual PTMs [166]. In this context,
the bottom-up installation of deﬁned PTMs at selected positions
within proteins represents a promising approach to decipher nat-
ure’s PTM code. Moreover, this approach offers a way to introduced
homogenous natural PTM mimics, which may have an important
impact on the generation of deﬁned pharmaceutical proteins cir-
cumventing the batch to batch variations often accompanied by
cell-based methods. Deﬁned PTMs such as mono- and
di-glycosylated nsAAs have been incorporated co-translationally
into proteins by CFPS [167]. Alternatively, the incorporation of
nsAAs with reactive handles also allows for the subsequent
post-translational modiﬁcation of synthesized proteins. For
instance, PTM mimics such as phosphotyrosine analogues [168]
or truly artiﬁcial ones like polyethylenglycol [169] have been
demonstrated. In principle, any protein modiﬁcation is feasible
via this approach, as the translational machinery does not regulate
the selected posttranslational modiﬁcation of amino acid side
chains. In this manner, the conjugation of biophysical probes
[107,170–172], afﬁnity handles [173] and an oriented immobiliza-
tion [174] can be achieved. Using photoreactive nsAAs, protein
interactions can be analyzed for example to investigate protein
trafﬁcking [175]. The incorporation of nsAAs with two correspond-
ing reactive groups enables direct conjugation of proteins by the
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allows for the generation of antibody-drug-conjugates [177],
antibody-display on virus-like-particles [178] and the covalent
linkage of single-chain antibody fragments to reporter proteins
[179]. In spite of the reported drawbacks of the active copper(I)
species in biological environments, the bioorthogonal CuAAC reac-
tion is extremely useful because of its relatively fast kinetics and
convincing selectivity even within complex biological environ-
ments [180]. Finally different reactive groups for novel bioorthog-
onal transformations are under investigation bearing great
potential with regard to improved selectivity and kinetics under
physiological conditions [180].
5. Conclusion
The implementation of nsAA incorporation into CFPS has in var-
ious examples been demonstrated to be beneﬁcial thereby provid-
ing a promising complementary platform to cell-based approaches.
In particular with regard to the characterization of novel incorpo-
ration methods, engineered orthogonal tRNA/synthetase pairs and
novel methodologies for improved nsAA incorporation efﬁciency,
CFPS offers a straightforward methodology susceptible to
high-throughput approaches. It is obvious that more randomized
mutant screenings will allow for the generation of aaRS with
enhanced activities thus facilitating nsAA incorporation. In this
context, eukaryotic cell-free system are particularly promising
platforms as mutant library screenings based on eukaryotic cells
suffer from a limited throughput. The broad diversity and the mul-
titude of CFPS systems currently available will eventually provide
new biological insights gained from the characterization of pro-
teins that are difﬁcult or even impossible to study in living cells
such as toxic proteins, proteins containing homogenous PTMs
and certain membrane proteins. The ongoing efforts of scientist
to enhance translation rates in combination with high-yielding
reaction formats are promising to pave the way towards the appli-
cation of eukaryotic cell-free systems for large-scale protein
production.
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